Mitochondrially Targeted Gene Therapy Rescues Visual Loss in a Mouse Model of Leber’s Hereditary Optic Neuropathy
Tsung-Han Chou, Zixuan Hao, Diego Alba, Angelina Lazo, Gabriele Gallo Afflitto, Jeremy D Eastwood, Vittorio Porciatti, John Guy, Hong Yu, Peter Koulen · 2023
Read Mitochondrially Targeted Gene Therapy Rescues Visual Loss in a Mouse Model of Leber’s Hereditary Optic Neuropathy by Tsung-Han Chou, Zixuan Hao, Diego Alba, Angelina Lazo, Gabriele Gallo Afflitto, Jeremy D Eastwood, Vittorio Porciatti, John Guy, Hong Yu, Peter Koulen (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10707051.txt.
Description
Tsung-Han Chou and co-authors test a gene therapy for an inherited disease that blinds young people by damaging the optic nerve. Their 2023 study uses mice bred to carry the same gene fault as human patients with this condition, called Leber's hereditary optic neuropathy. No firm cure exists for it.
The team used a virus tuned to enter the cell's power stations, where the faulty gene sits, and deliver a healthy copy. Treated mice kept sharper vision than untreated ones and showed a stronger blood-flow response in the eye. Counts of the nerve cells that carry sight signals also held up better. The authors say the approach partly rescued sight and merits further study as a possible treatment.
Catalog record
| CREATOR | Tsung-Han Chou, Zixuan Hao, Diego Alba, Angelina Lazo, Gabriele Gallo Afflitto, Jeremy D Eastwood, Vittorio Porciatti, John Guy, Hong Yu, Peter Koulen |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |